BRIEF: Pace SARS-CoV-2 wastewater testing capabilities are a result of a collaboration between Environmental and Life Sciences. Because Pace provides quantifiable data, clients can monitor changes in the levels of RNA from the SARS-CoV-2 virus in wastewater, they are able to better prepare for COVID-19 outbreaks and isolate areas to prevent spreading. This is in contrast to competitive offerings that simply detect the presence of the virus (pass/fail detection).
TARGET(S): Through this campaign, we have targeted wastewater systems, Universities, federal prisons, and state correctional facilities.
These campaign components align to create a clear consistent competitive message, driving pull to our website to learn more about our COVID-19 wastewater testing capabilities.
- Pace provides actionable, quantitative data
- Clients can use Pace data to monitor increases in RNA levels over time to prepare for outbreaks and isolate areas to prevent spreading
- Enables the ability to test populated areas in a non-intrusive way
MQLs Generated: 258 (last update 1/13/21)
Revenue Generated: $901,295.